s 99

S-99 is a high purity chemical that targets ASK and is important for Immunology, Inflammation, Cancer research.

(2S,3R)-LP99 is the less active enantiomer of LP99.

Carbamic acid, methyl-, m-((2-propynyloxy)methoxy)phenyl ester is a bioactive chemical.

GS-9901 is a selective, orally active and potent PI3Kδ inhibitor (IC50: 1 nM) for the study of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.

AS-99 is a first-in-class, potent, and selective ASH1L histone methyltransferase inhibitor (IC50= 0.79 μM, Kd= 0.89 μM) with anti-leukemic activity, blocking cell proliferation, inducing apoptosis and differentiation, downregulating MLL fusion target genes, and reducing the leukemia burden in vivo[1].

AS-99 TFA is a potent, and selective ASH1L histone methyltransferase inhibitor with an IC50 of 0.79 μM. It exhibits robust anti-leukemic activity by blocking cell proliferation, inducing apoptosis and differentiation. AS-99 TFA exerts its effects by downregulating MLL fusion target genes and has been shown to significantly reduce leukemia burden in vivo.

TES-991 is a potent and selective inhibitor of human α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD), with an IC50 of 3 nM.

Inarigivir soproxil (SB9200) is an agonist of innate immunity that demonstrates effective antiviral activity against resistant hepatitis C virus (HCV) variants, with EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems.

KMS99220 is an orally active Keap-1 activator that acts as an Nrf2 inhibitor protein. It enhances Nrf2 nuclear translocation, increases the expression of antioxidant enzymes (such as heme oxygenase-1) and proteasome subunit genes, and alleviates oxidative stress and protein aggregation damage. KMS99220 is applicable for research in Parkinson's disease (PD).

MS99-β-Gal (Gal-MS99) is a galactose-modified NPM-ALK PROTAC degrader. It is selectively hydrolyzed by SA-β-galactosidase (SA-β-gal) and esterases specifically in senescent cancer cells, releasing MS99, which targets the degradation of the NPM-ALK fusion protein. In senescent Karpas 299 cells, MS99-β-Gal has an IC50 value of 454.8 nM, significantly lower than its IC50 of 2.162 μM in normal Karpas 299 cells. This compound is applicable in cancer research.

MIPS-9922 is a potent and selective PI3Kβ inhibitor with antiplatelet activity. MIPS-9922 inhibited integrin αIIbβ3 activation and αIIbβ3 dependent platelet adhesion to immobilized vWF under high shear. MIPS-9922 also potently inhibited ADP-induced washe

Entospletinib (GS-9973) is a Syk inhibitor (IC50=7.7 nM) with selective, oral activity. Entospletinib has potential value in the treatment of a variety of hematological malignancies and immune-related diseases.

S9947 is a Kv1.5/IKur channel blocker, suppressing both cloned (Kv1.5) and native (IKur) cardiac potassium current.

L6H9 is a novel inhibitor of myeloid differentiation factor 2 (MD2), suppressing HG-induced expression of ACE and AT1 receptor and Angiotensin II (AngII) production in renal NRK‐52E cells, resulting in the decrease in fibrosis markers such as TGF-β and collagen IV.

KS99 is a dual inhibitor of BTK and tubulin polymerization.

AS-99 is a first-in-class, potent, and selective inhibitor of the ASH1L histone methyltransferase, displaying anti-leukemic activity with an IC50 of 0.79 µM and a Kd of 0.89 µM. It inhibits cell proliferation, induces apoptosis and differentiation, downregulates MLL fusion target genes, and effectively reduces leukemia burden [in vivo].

FLA-99 is a biochemical compound that selectively inhibits the enzymatic breakdown of inositol-1,4,5-triphosphate (IP3) by inositol-1,4,5-triphosphate 5-phosphatase. By preventing IP3 degradation, FLA-99 modulates intracellular calcium signaling, making it a useful tool in signal transduction and phosphoinositide pathway research.

Oclacitinib (PF-03394197)(PF03394197) is a potent and selective JAKs inhibitor with IC50 of 10-99 nM; not inhibit a panel of 38 non-JAK kinases (IC50 's > 1000 nM).

Anti-inflammatory agent 84 (Compound 4D) is a coumarin derivative with notable antibacterial and anti-inflammatory properties. It inhibits E. coli, Candida albicans, Staphylococcus aureus, and methicillin-resistant S. aureus (MRSA) with MIC values of 312, 156, 19, and 316 µg/mL, respectively. Additionally, it suppresses biofilm formation of S. aureus, E. coli, and MRSA, with IC50 values of 185, 321, and 99 µM, respectively. Anti-inflammatory agent 84 also reduces nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophages.

Rugulotrosin A is an antibiotic originally isolated from Penicillium, active against the Gram-positive bacteria E. faecalis, B. cereus, B. subtilis, and S. aureus with 99% lethal dose (LD99) values of 1.6, 3.1, 5.5, and 200 μg/ml, respectively. Rugulotrosin A is inactive against Gram-negative bacteria.

(S)-2-Amino-2-cyclopropylacetic acid is a useful organic compound for research related to life sciences. The catalog number is T66527 and the CAS number is 49606-99-7.

Tetrakis[(S)-(+)-(1-adamantyl)-(N-phthalimido)acetato]dirhodium(II) is a useful organic compound for research related to life sciences. The catalog number is T67239 and the CAS number is 909389-99-7.